Search

everythinglearnresearchcommunity

for

Search:↓

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

SCD1 is important for hair growth by keeping the connection in skin cells where hair stem cells live stable.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

ERG increases SOX9, promoting prostate cancer growth and invasion.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

The extract of Silybum marianum, Manganese PCA, and Lespedeza capitata can boost hair growth and extend the growth phase when combined in a serum.

Silybum marianum extract, Manganese PCA, and Lespedeza capitata extract may help with hair growth and anchorage, potentially aiding in hair loss treatment.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Skin reactions from cancer treatments might predict how well the treatments work.

EGFR helps control how hair grows and forms without needing p53 protein.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

ATP helps prevent skin damage from vandetanib by reducing stress.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.